Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Abeona Therapeutics (ABEO) has a market cap of $0.22 billion USD. According to our data, Abeona Therapeutics is ranked No.6997 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.22 B |
-7.72%
|
| Dec 31, 2024 | $0.24 B |
11.18%
|
| Dec 29, 2023 | $0.22 B |
62.66%
|
| Dec 30, 2022 | $0.13 B |
-63.76%
|
| Dec 31, 2021 | $0.37 B |
-78.34%
|
| Dec 31, 2020 | $1.71 B |
-51.99%
|
| Dec 31, 2019 | $3.56 B |
-54.20%
|
| Dec 31, 2018 | $7.78 B |
-54.95%
|
| Dec 29, 2017 | $17.27 B |
226.80%
|
| Dec 30, 2016 | $5.29 B |
44.35%
|
| Dec 31, 2015 | $3.66 B |
-2.61%
|
| Dec 31, 2014 | $3.76 B |
-72.40%
|
| Dec 31, 2013 | $13.62 B |
4.17%
|
| Dec 31, 2012 | $13.08 B |
-83.33%
|
| Dec 30, 2011 | $78.47 B |
-41.94%
|
| Dec 31, 2010 | $135.14 B |
-24.62%
|
| Dec 31, 2009 | $179.28 B |
232.32%
|
| Dec 31, 2008 | $53.95 B |
-69.54%
|
| Dec 31, 2007 | $177.10 B |
16.07%
|
| Dec 29, 2006 | $152.58 B |
7.69%
|
| Dec 30, 2005 | $141.68 B |
-85.31%
|
| Dec 31, 2004 | $964.51 B |
-32.44%
|
| Dec 31, 2003 | $1.428 T |
249.33%
|
| Dec 31, 2002 | $408.69 B |
-66.22%
|
| Dec 31, 2001 | $1.210 T |
-11.20%
|
| Dec 29, 2000 | $1.362 T |
172.70%
|
| Dec 31, 1999 | $499.57 B |
-11.11%
|
| Dec 31, 1998 | $562.01 B |
-79.43%
|
| Dec 31, 1997 | $2.732 T |
-27.08%
|
| Dec 31, 1996 | $3.747 T |
-29.41%
|
| Dec 29, 1995 | $5.308 T |
88.89%
|
| Dec 30, 1994 | $2.810 T |
-55.00%
|
| Dec 31, 1993 | $6.245 T |
-54.55%
|
| Dec 31, 1992 | $13.738 T |
-54.17%
|
| Dec 31, 1991 | $29.974 T |
500.00%
|
| Dec 31, 1990 | $4.996 T |
-55.56%
|
| Dec 29, 1989 | $11.240 T |
-59.09%
|
| Dec 30, 1988 | $27.476 T |
-12.00%
|
| Dec 31, 1987 | $31.223 T |
-52.83%
|
| Dec 31, 1986 | $66.193 T |
-5.36%
|
| Dec 31, 1985 | $69.939 T |
19.15%
|
| Dec 31, 1984 | $58.699 T |
-11.32%
|
| Dec 30, 1983 | $66.193 T |
-56.56%
|
| Dec 31, 1982 | $152.368 T |
3.39%
|
| Dec 31, 1981 | $147.372 T |
11.32%
|
| Dec 31, 1980 | $132.385 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
 uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
 REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
 Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
 Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
 Boundless Bio
BOLD
|
$57.31 M |
0.000 M
|
USA
|
 Krystal Biotech
KRYS
|
$4.41 B |
-0.000 M
|
USA
|
 Adverum Biotechnologies
ADVM
|
$92.99 M |
-0.000 M
|
USA
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
 Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
| Market Cap | = | ABEO Stock Price | * | ABEO Shares Outstanding |
| = | $5.14 | * | 43.59 M | |
| = | $0.22 B |